FG-4592: Clinical Trials

9 trials of FG-4592, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 9
Phase 31Completed 1

Follow FG-4592: new trials by email Literature Review of FG-4592 trials Research Report on FG-4592

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia
Roxadustat - Chemotherapy Induced Anemia
Phase 2CompletedKyntra Bio922019-08-202022-06-03
Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)
FG-4592, Placebo - Anemia, Myelodysplastic Syndrome
Phase 2 / Phase 3CompletedKyntra Bio432018-06-062023-05-03
Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease
Roxadustat - Chronic Kidney Disease, End Stage Renal Disease
Phase 2CompletedKyntra Bio152012-05-182021-10-01
Study of FG-4592 in Subjects With Chronic Kidney Disease in China
FG-4592, Placebo - Anemia in Chronic Kidney Disease
Phase 2CompletedKyntra Bio912011-12-012014-03-03
Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China
FG-4592, Epoetin Alfa - Anemia in End Stage Renal Disease
Phase 2CompletedKyntra Bio962011-09-012013-02-04
Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment
Roxadustat, Oral Iron, IV Iron - Dialysis, Anemia
Phase 2CompletedKyntra Bio602011-07-212021-10-01
Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
Roxadustat - Chronic Kidney Disease, Anemia
Phase 2CompletedKyntra Bio1452010-10-292022-02-10
Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis
Roxadustat, Epoetin Alfa, Placebo - End Stage Renal Disease, Anemia
Phase 2CompletedKyntra Bio1612010-05-172022-01-11
Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis
Roxadustat, Placebo - Chronic Kidney Disease, Anemia
Phase 2CompletedKyntra Bio1172006-11-012021-11-19

Conditions studied

Anemia (9)  ·  Renal Insufficiency, Chronic (4)  ·  Kidney Failure, Chronic (3)  ·  Myelodysplastic Syndromes (1)

Sponsors

Kyntra Bio (9)

Countries

United States (6)  ·  China (3)  ·  Puerto Rico (2)  ·  Hong Kong (1)  ·  Russia (1)  ·  Singapore (1)

Top investigators

Marietta Franco (1)  ·  Peony Yu (1)

Results publications

PMID 36005278, PMID 26238121